SHIKARI® Q-NIVO
 Matriks Biotek Nivolumab ELISA has been specially developed for the quantitative analysis of free Nivolumab in serum and plasma samples at high specificity.
SHIKARI® S-ATN
Required Volume 
Total Time 
Sample
Sample Number
Detection Limit 
Spike Recovery 
Shelf Life
10ul
70 min
Serum, plasma
96
10ng/mL
85-115%
1 year
The Matriks Biotek anti-Nivolumab (Opdivo®) Enzyme-Linked-ImmunoSorbentAssay (ELISA) Kit is intended for the qualitative determination of antibodies to Nivolumab (Opdivo®) in serum and plasma. 
It is for professional use only.
Calibration Curve
SHIKARI® Q-NIVO & S-ATN
Nivolumab (Opdivo®)
Enzyme immunoassay for the quantitative determination of Nivolumab (Opdivo®) in serum and plasma
Enzyme immunoassay for the qualitative determination (screening) of antibodies to Nivolumab (Opdivo®) in serum and plasma
Required Volume 
Total Time 
Sample
Sample Number
Detection Limit 
Spike Recovery 
Shelf Life
10ul
140 min
Serum, plasma
96
+/-
-
1 year
Q-NIVOv1: $943.00                                         Lead time: 1-2 weeks
S-ATNv1: $878.00                                           Lead time: 1-2 weeks
.....................................................
.....................................................
Drug Measurement
Anti-drug Antibody Measurement
Quantitative
Qualitative
Nivolumab (Opdivo®)
PD-1, PD-L1 and CTLA-4
Q-NIVO
(Free)

#TR-Q-NIVOv1
S-ATNv1
(Free)

#TR-ATNv1
Iwai North America Inc.

541 Taylor Way Suite# 4
 San Carlos, CA 94070
 Phone : (650) 486-1541
Fax : (650) 394-8638
 Open weekdays 9 AM-6 PM (PST)
.........................................................................................................................................................................................................................................................